One potential candidate, carbohydrate binding agents (CBAs) has been shown to prevent CD4 T cell HIV infection, cell–cell fusion, binding to DC-SIGN and trans-infection of CD4 T cells without affecting the growth of commensal Lactobacilli [84]. Here, CD209 is linked to infection.